FDA Safety Labeling Changes: Sarafem, Tequin, Factive

The FDA has approved revisions to the safety labeling for fluoxetine (Sarafem), gatifloxacin (Tequin), and gemifloxacin mesylate (Factive).Yael Waknine

Continue to FDA Safety Labeling Changes: Sarafem, Tequin, Factive on Medscape Medical News Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz